Related Experiment Video

Updated: Apr 15, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K

Plasma cephalins of patients with acute myocardial infarction

M M Nothman1, S Proger

  • 1New England Medical Center Hospital, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.

Circulation
|April 1, 2015
PubMed

Insights

Plasma levels of phosphatidyl ethanolamine and phosphatidyl serine are significantly elevated in acute myocardial infarction patients compared to those with chronic coronary heart disease or healthy individuals. These phospholipid levels gradually decrease post-event.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Chemistry

Background:

  • Phospholipids, including phosphatidyl ethanolamine and phosphatidyl serine, play crucial roles in cellular function.
  • Alterations in plasma phospholipid profiles may indicate significant physiological changes, such as those occurring during acute myocardial infarction (AMI).

Purpose of the Study:

  • To investigate and quantify the changes in plasma levels of phosphatidyl ethanolamine and phosphatidyl serine in patients experiencing acute myocardial infarction.
  • To compare these levels with those found in patients with chronic coronary heart disease and healthy controls.

Main Methods:

  • Plasma samples were collected from patients with AMI, chronic coronary heart disease, and healthy individuals.
  • Concentrations and relative percentages of phosphatidyl ethanolamine and phosphatidyl serine were measured in plasma.
  • Follow-up measurements were taken post-AMI to observe changes over time.

Main Results:

  • Plasma phosphatidyl ethanolamine levels were 50-100% higher in AMI patients versus chronic coronary heart disease patients, and up to 400% higher than in healthy individuals.
  • Plasma phosphatidyl serine levels were approximately 50% higher in AMI patients compared to chronic coronary heart disease patients, and up to 300% higher than in healthy individuals.
  • The relative share of phosphatidyl ethanolamine and phosphatidyl serine in total phospholipids was significantly increased in AMI patients.

Conclusions:

  • Acute myocardial infarction is associated with substantial increases in plasma phosphatidyl ethanolamine and phosphatidyl serine.
  • These phospholipid levels demonstrate a gradual decline following an acute cardiac event, with distinct recovery timelines for each.
  • Monitoring these specific phospholipids may offer insights into the pathophysiology and recovery phases of myocardial infarction.

More Related Videos

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

4.8K
A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

17.2K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
498
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
330
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
481
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K